• Viewed 10,240 times by 3014 users (Last 30 days)
  • print Created with Sketch. Print
ARG
Click for more information
0.85% $1.19

Argosy Property Limited Ordinary Shares - Charts / Financials

watchlist Created with Sketch. Add to my watchlist
Real Estate REIT - Diversified
refresh Created with Sketch. REFRESH
Day
Open $1.18   Day High $1.20   Day Low $1.17
Daily Volume 759933
Bids   Sellers
Number Price Volume   Number Price Volume
0 $1.18 9   0 $1.20 6022

Data source: Refinitiv

(20min delay)
Last
$1.19 		Change
0.010(0.85%) 		Mkt cap ! n/a
Open High Low Value Volume
$1.18 $1.20 $1.17 $902.5K 759.9K

Buyers (Bids)

No. Vol. Price($)
0 9 $1.18
 

Sellers (Offers)

Price($) Vol. No.
$1.20 6022 0
Last trade - 13.00pm 30/08/2024 (20 minute delay) ?

Top Stories

 Week 35 Wrap: HotCopper’s top watched; ‘iron ore winter’ has started; Oz inflation @ 3.5% MoM; Harris fracking flip 

Earlier this month, Chinese steelmaker giant Baowu released commentary that saw iron ore prices drop when it declared a “long and harsh winter” ahead for iron ore miners
Consumer Staples Shine Amid Retail Slump – Key Stocks to Watch The Consumer Staples sector's resilience across different market conditions makes it a compelling choice in a weaker economy.
Consumers cautious according to Harvey Norman, as profit slumps 35% in FY24 Harvey Norman Holdings Ltd has reported its financial results for the 2024 fiscal year, reporting a fall in profit and sales.
Tamboran kicks off Shenandoah South pilot project with SS-2H well spud Tamboran (ASX:TBN) has spud the Shenandoah South 2H (SS-2H) well in permit EP 98, officially kicking off its Shenandoah South Pilot Project (SSPP) drilling program.
PYC achieves key designation for drug aiming to treat blinding eye disease ADOA PYC Therapeutics Ltd has received a special designation from the FDA for its drug PYC-001 to treat a childhood-originating eye disease.
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.